CA
TWST icon

CoreCap Advisors’s Twist Bioscience TWST Stock Holding History

CoreCap Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$275 – 3240
2025
Q1 		$275 Buy
+7
New +$315 ﹤0.01% 2834
2022
Q1 		– Sell
-105
Closed -$8K – 1985
2021
Q4 		$8K Buy
+105
New +$10.8K ﹤0.01% 1630

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CoreCap Advisors's TWST Position: Q2 2025 in Review

CoreCap Advisors sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 7 shares — an estimated $275 sold.

CoreCap Advisors first reported a position in TWST in Q4 2021 and held it in 2 quarters. The position peaked at $8K in Q4 2021. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • CoreCap Advisors reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • CoreCap Advisors sold 7 Twist Bioscience shares in Q2 2025, an estimated $275.
  • CoreCap Advisors first reported a position in Twist Bioscience in Q4 2021 and held it in 2 quarters.
  • CoreCap Advisors's Twist Bioscience position peaked at $8K in Q4 2021.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.